SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-24-001160
Filing Date
2024-07-30
Accepted
2024-07-30 17:20:53
Documents
13
Period of Report
2024-07-24
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e5843_8k.htm   iXBRL 8-K 23830
  Complete submission text file 0001731122-24-001160.txt   196234

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE avxl-20240724.xsd EX-101.SCH 3009
3 XBRL LABEL FILE avxl-20240724_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE avxl-20240724_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT e5843_8k_htm.xml XML 3687
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 980608404 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 241158922
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)